USPTO serial 79270401
LUYE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 15, 2020
- Examiner
- KEELEY, ALISON REBECCA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with LUYE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Shandong Luye; Pharmaceutical Co., Ltd.
Shandong Province, CN
Other trademarks owned by Shandong Luye; Pharmaceutical Co., Ltd.
Shandong Luye; Pharmaceutical Co., Ltd.
Shandong Province, CN
Other trademarks owned by Shandong Luye; Pharmaceutical Co., Ltd.
Shandong Luye; Pharmaceutical Co., Ltd.
Shandong Province, CN
Other trademarks owned by Shandong Luye; Pharmaceutical Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles P. LaPolla
Charles P. LaPolla Phillips Nizer LLP485 Lexington Ave - 14th FlNew York, NY 10017UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicinal preparations for the treatment of infectious diseases and for use in oncology; nutraceutical preparations for use as a dietary supplement; drugs for medical purposes in the nature of antibiotics; pharmaceutical preparations acting on the central nervous system; cardiovascular pharmaceutical preparations; digestives for pharmaceutical purposes; drugs for the treatment of intestinal disorders; drugs and preparations for the treatment of gastrointestinal disease; drugs for the treatment of cancer; biological preparations for the treatment of cancer; stem cells for medical purposes; injectable pharmaceuticals for the treatment of cardiovascular disorders; pain relief medication; chemical preparations for removal and treatment of tumors; contraceptive preparations; medicinal herbs; pharmaceutical preparation for the treatment of musculoskeletal disease; radio pharmaceuticals for the treatment of tumors; diagnostic preparations for medical purposes; biochemical drugs for the treatment of cardiovascular diseases; medical reagents for gene detection; radioactive substances for medical purposes; gases for medical purposes; disinfectants; cultures of microorganisms for medical or veterinary use; disinfectants for chemical toilets; chemical reagents for veterinary purposes; mothproofing preparations; dressings, medical; teeth filling material | ACTIVE | — |
| 035 | Retail services, namely, retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; import-export agency services; wholesale services, namely, wholesale ordering services for pharmaceutical, veterinary and sanitary preparations and medical supplies; marketing services; provision of an on-line marketplace for buyers and sellers of goods and services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Shandong Luye; Pharmaceutical Co., Ltd.
- Other trademarks owned by Shandong Luye; Pharmaceutical Co., Ltd.
- Other trademarks owned by Shandong Luye; Pharmaceutical Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Similar marks named LUYE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 15, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 2, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 2, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 2, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 13, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 31, 2020 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Dec 31, 2020 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Dec 15, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 15, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 30, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 30, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 27, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 10, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 10, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 10, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 27, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 15, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 15, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 14, 2020 | ALIE | ASSIGNED TO LIE | — |
| May 11, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 14, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 22, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 22, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 2, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 1, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 31, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 29, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 24, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |